Modular Medical (NASDAQ:MODD – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.90) earnings per share for the quarter, FiscalAI reports.
Modular Medical Stock Up 1.8%
NASDAQ MODD traded up $0.04 on Tuesday, hitting $1.95. The stock had a trading volume of 12,796 shares, compared to its average volume of 128,027. Modular Medical has a one year low of $1.20 and a one year high of $16.20. The stock has a market cap of $18.48 million, a price-to-earnings ratio of -0.22 and a beta of 0.52. The company’s 50-day moving average is $2.10 and its two-hundred day moving average is $4.67.
Wall Street Analysts Forecast Growth
Several equities analysts have recently commented on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Modular Medical in a report on Monday, September 21st. Wall Street Zen raised Modular Medical from a “strong sell” rating to a “sell” rating in a report on Sunday, August 23rd. One research analyst has rated the stock with a Sell rating. According to MarketBeat, Modular Medical currently has an average rating of “Sell”.
Institutional Investors Weigh In On Modular Medical
A hedge fund recently raised its position in Modular Medical stock. AWM Investment Company Inc. increased its holdings in Modular Medical, Inc. (NASDAQ:MODD – Free Report) by 20.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 441,095 shares of the company’s stock after buying an additional 74,429 shares during the quarter. AWM Investment Company Inc. owned about 7.38% of Modular Medical worth $1,985,000 at the end of the most recent reporting period. 27.47% of the stock is currently owned by institutional investors and hedge funds.
Modular Medical Company Profile
Modular Medical, Inc. is a medical-device company focused on developing insulin-delivery technology for people with diabetes. Its work centers on making pump therapy simpler and more accessible for people who may find traditional insulin pumps difficult to use. The company’s lead product, MODD1, is a wearable insulin-delivery system designed to provide an alternative to multiple daily insulin injections. Modular Medical describes the device as a simplified pump intended to make insulin delivery easier to manage.
Read More
- Five stocks we like better than Modular Medical
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
- Tyson Foods’ Earnings Beat Hides a Warning for Consumer Staples Dividend Investors
- 3 Stocks in an Overlooked Corner of Infrastructure With Hundreds of Billions at Stake
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.
